Saitama Medical University · Faculty of Medicine / Graduate School of Medicine · 講師

Research keywordsJAK-STAT inhibitors・collagen-induced arthritis・regulatory T cells・astrogliosis・IgG4-related disease・coronary aneurysm・brain microinflammation・neuroimmune circuits

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Efficacy and tolerability of six-week extended dosing interval with tocilizumab therapy in a prospective cohort as remission maintenance in patients with rheumatoid arthritis
• A novel JAK-STAT inhibitor, 2-[(3-Carbamoyl-2-thienyl)amino]-2-oxoethyl(2,6-dichlorophenyl)acetate, suppresses helper T cell differentiation in vitro and collagen-induced arthritis in vivo.
• Generation and application of human induced-stem cell memory T cells for adoptive immunotherapy
• Systematic review and meta-analysis for 2023 clinical practice guidelines of the Japan research committee of the ministry of health, labour, and welfare for intractable vasculitis for the management of ANCA-associated vasculitis.

• 2025/10～2026/09 腎臓・糸球体を構成する細胞群の Single cell sorting と培養基盤技術の確立2025 · 研究課題・受託研究・科研費
• 2024/04～2027/03 組織制御性T細胞subpopulationによる免疫寛容と腎線維化制御機構の解明 若手医師育成助成研究2024 · 研究課題・受託研究・科研費
• 2020/10～ 腎疾患における免疫細胞と腎固有細胞とのクロストーク2020 · 研究課題・受託研究・科研費
• GATA3陽性制御性T細胞と関節内固有細胞とのクロストーク

• Official profile